2100 WHARTON STREET, PITTSBURGH, PA
Market cap: $7.0B (12/18/2025)
Price: $240.80
Announces Third Quarter 2025 Financial and Operating Results
Other Events
Announces Second Quarter 2025 Financial and Operating Results
Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa
Investor Presentation
Shareholder votes
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus Filed Pursuant to Rule 424(b)(2)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence
S-1MEF